en
Scientific article
Open access
English

Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient

Published inInternational journal of infectious diseases, vol. 55, p. 24-26
Publication date2017
Abstract

Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. A 30-year-old woman diagnosed with acute myelomonocytic leukemia and needing allo-HSCT presented pulmonary and cerebral infection due to Rhizomucor pusillus. This fungal infection was treated with surgical treatment and posaconazole delayed-release tablets. This strategy allowed reaching high drug levels that could not be obtained with the posaconazole solution.

Keywords
  • Mucormycosis
  • Posaconazole delayed-release tablets
  • Rhizomucor pusillus
  • Zygomycosis
Citation (ISO format)
ANDREY, Diego Olivier et al. Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient. In: International journal of infectious diseases, 2017, vol. 55, p. 24–26. doi: 10.1016/j.ijid.2016.12.014
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1201-9712
538views
113downloads

Technical informations

Creation03/09/2017 11:01:00 AM
First validation03/09/2017 11:01:00 AM
Update time03/15/2023 1:37:40 AM
Status update03/15/2023 1:37:40 AM
Last indexation05/02/2024 6:19:25 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack